Clinical Trial Update: Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations [Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 2 study evaluating talazoparib in patients with advanced cancers and DNA repair variations, and the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• Talzenna (talazoparib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 | Phase 2 | Status: RECRUITING